Asia Australia Central America North America South America Eastern Europe Western Europe Middle East
Product Description
TAGRIX is indicated for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC)
Tell us about your requirement
Price:
Quantity
Select Unit
50
100
200
250
500
1000+
Additional detail
Mobile number
Email
Confirm Your Requirement
Verification Code
Did not receive yet?
Resend OTP
Youre Done!
We have received your requirements and will reply shortly with the best price.